A new study presented at the American Society of Clinical Oncology annual meeting in Chicago suggest that short-term androgen deprivation therapy (STADT) in combination with radiotherapy (RT) in men with intermediate-risk prostate cancer is associated with better outcomes compared with dose-escalated radiotherapy alone.
Read MoreProstate cancer, aka the “silent killer”, has always been known as an older man’s disease. Being the second most common cancer among men in the United States, prostate cancer occurs mainly in older men.
Read MoreResearchers from the Pharmacology Department at the Indiana University School of Medicine may have found a future way to cure prostate cancer that metastasizes to the bone.
Read MoreA new study from Duke University Medical Center published in the journal, BMC Medicine, showed that what you eat can influence the risk of prostate cancer. Here's what men need to know.
Read MoreMen diagnosed with prostate cancer that has not metastasized generally have a long life expectancy. Most men with prostate cancer don’t die from the disease, but instead die of unrelated causes. This study looks at to what extent post-diagnostic diet may affect disease-specific and overall mortality.
Read MoreThis is the first study that has investigated the connection between BMI and prostate cancer-specific outcomes among patients treated with definitive EBRT in the era of dose-escalated IMRT with daily IGRT.
Read MoreHow are the “same” cancers treated differently? Not all gleason scores of 6, 7, or 8+ can be treated equally. How do we individualize the care with the diagnostic tools available to us, when patients present with similar clinicopathologic characteristics?
Read MoreWhat is prostatitis? Quite simply, it is a prostate infection. This condition involves inflammation of the prostate, the small walnut shaped male gland that produces seminal fluid. The direct causes of prostatitis are not fully known by the medical community, but some of the theories include past bacterial infections, irritation from urine back up, lower urinary tract issues, parasites, or viruses.
Read MoreAccording to a new study at the University of Maryland School of Medicine, men who have had testicular cancer may have an increased risk for prostate cancer. While there have been previous studies that have shown an increased risk of prostate cancer in men who have previously had testicular cancer, this is the first one to observe the risk of getting intermediate or high-risk prostate cancer.
Read MoreA new study released in the journal, Nature, evaluated a newer approach to treating metastatic prostate cancer through Integrating chemo hormonal therapy and surgery. The method was applied to known or suspected lymph node metastatic prostate cancer.
Read MoreThere has been much controversy as to whether or not cycling has an effect on PSA or the emergence of prostate cancer. Although there have been many contradictory studies, overall it seems that riding your bike does not increase your risk for prostate cancer.
Read MoreWhy is this important? Because prostate cancer is to men as breast cancer is to women. And just as with any other cancer, an early understanding of your risk factors and how to potentially reduce them is tremendously valuable. We explore.
Read More
